GB9822737D0 - Safety enhancing pharmaceutical compositions - Google Patents

Safety enhancing pharmaceutical compositions

Info

Publication number
GB9822737D0
GB9822737D0 GBGB9822737.4A GB9822737A GB9822737D0 GB 9822737 D0 GB9822737 D0 GB 9822737D0 GB 9822737 A GB9822737 A GB 9822737A GB 9822737 D0 GB9822737 D0 GB 9822737D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
safety enhancing
enhancing pharmaceutical
safety
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9822737.4A
Other versions
GB2327191A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REDPATH TREVOR H
Original Assignee
REDPATH TREVOR H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9412995A external-priority patent/GB9412995D0/en
Application filed by REDPATH TREVOR H filed Critical REDPATH TREVOR H
Priority to GB9822737A priority Critical patent/GB2327191A/en
Publication of GB9822737D0 publication Critical patent/GB9822737D0/en
Publication of GB2327191A publication Critical patent/GB2327191A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB9822737A 1994-06-28 1995-04-19 Pharmaceutical uses of granisetron Withdrawn GB2327191A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9822737A GB2327191A (en) 1994-06-28 1995-04-19 Pharmaceutical uses of granisetron

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9412995A GB9412995D0 (en) 1994-06-28 1994-06-28 Safety enhancing pharmaceutical compositions of an active indazole
GB9822737A GB2327191A (en) 1994-06-28 1995-04-19 Pharmaceutical uses of granisetron
GB9507929A GB2291591A (en) 1994-06-28 1995-04-19 Pharmaceutical uses of granisetron

Publications (2)

Publication Number Publication Date
GB9822737D0 true GB9822737D0 (en) 1998-12-16
GB2327191A GB2327191A (en) 1999-01-20

Family

ID=26305155

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9822737A Withdrawn GB2327191A (en) 1994-06-28 1995-04-19 Pharmaceutical uses of granisetron

Country Status (1)

Country Link
GB (1) GB2327191A (en)

Also Published As

Publication number Publication date
GB2327191A (en) 1999-01-20

Similar Documents

Publication Publication Date Title
GB9417524D0 (en) Pharmaceutical compositions
HU9503199D0 (en) Pharmaceutical basic compositions
HU9500229D0 (en) Pharmaceutical composition against osteoporosis
EP0803255A4 (en) Medicinal composition
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
ZA954469B (en) Pharmaceutical compositions
ZA959081B (en) Pharmaceutical compositions
GB9406835D0 (en) Pharmaceutical compositions
GB9822734D0 (en) Safety enhancing pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
HU9400096D0 (en) Pharmaceutical compositions
HU9601821D0 (en) Pharmaceutical compositions
GB9822737D0 (en) Safety enhancing pharmaceutical compositions
GB2308545A (en) Pharmaceutical compositions
GB2285923B (en) Pharmaceutical compositions containing N-acetal-cysteine
GB9406121D0 (en) Pharmaceutical compositions
ZA954838B (en) Pharmaceutical compositions
GB9413423D0 (en) Pharmaceutical compositions
GB9405948D0 (en) Pharmaceutical compositions
GB9411933D0 (en) Pharmaceutical compositions
GB9401872D0 (en) Pharmaceutical compositions
GB9404457D0 (en) Pharmaceutical compositions
GB9405879D0 (en) Pharmaceutical compositions
GB9407235D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)
711Q Appeals lodged - section 117